Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Special Independent Committee
View:
Post by Ingiboy on Aug 30, 2024 4:00am

Special Independent Committee

From the N/R yesterday:
"Following the negotiation and recommendation of a special independent committee of RepliCel Life Sciences Inc.'s board of directors......"


"the special committee is unanimous in its belief that the transaction is in the best interests of the company and its shareholders," said David Hall, chair of the special committee."

The use the word "independent"  is a bit of a oxymoron here.  How independent can this committee be if it is made up of the Directors of the company.  Also we have no idea if any of the members have any connection to this new numbered company of Andrew Schutte.
I will say it again, this is the biggest boondoggle in the history of takeovers.  He is offering to simply take over the company and give the minority shareholders an 8% Royalty or quasi Dividend if and when there is any profit after expenses of this new numbered company.  Wow, how generous is that.  If the assets of Replicel are sold the shareholders of which he is one get 75% of the residuals. Why as a the existing CEO of the company is he not actively trying to sell the company and 100% of the residuals go to the shareholders and forget about this silly takeover.
Comment by MetzGER on Aug 30, 2024 4:25am
If you don't want to get stolen please vote NO! Please all vote NO !!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities